First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) Trading Up 1.6% – Still a Buy?

Shares of First Trust Nasdaq Pharmaceuticals ETF (NASDAQ:FTXH) were up 1.6% on Thursday . The company traded as high as $38.59 and last traded at $38.52. 14,818 shares were traded during mid-day trading, an increase of 30% from the average daily volume of 11,400 shares. The stock had previously closed at $37.92.

First Trust Nasdaq Pharmaceuticals ETF Trading Up 1.6%

The firm has a market cap of $36.59 million, a price-to-earnings ratio of 14.51 and a beta of 0.45. The firm has a 50 day moving average price of $36.10 and a 200-day moving average price of $34.82.

First Trust Nasdaq Pharmaceuticals ETF Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 30th. Shareholders of record on Thursday, June 25th were issued a dividend of $0.092 per share. This is an increase from First Trust Nasdaq Pharmaceuticals ETF’s previous quarterly dividend of $0.06. The ex-dividend date was Thursday, June 25th. This represents a $0.37 annualized dividend and a yield of 1.0%.

Hedge Funds Weigh In On First Trust Nasdaq Pharmaceuticals ETF

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the business. NBC Securities Inc. raised its position in shares of First Trust Nasdaq Pharmaceuticals ETF by 33.0% during the 4th quarter. NBC Securities Inc. now owns 1,325 shares of the company’s stock worth $44,000 after purchasing an additional 329 shares during the last quarter. Raymond James Financial Inc. acquired a new stake in First Trust Nasdaq Pharmaceuticals ETF during the 2nd quarter valued at $57,000. Kestra Advisory Services LLC acquired a new stake in First Trust Nasdaq Pharmaceuticals ETF during the 4th quarter valued at $59,000. Flagship Harbor Advisors LLC acquired a new stake in First Trust Nasdaq Pharmaceuticals ETF during the 4th quarter valued at $205,000. Finally, Flputnam Investment Management Co. purchased a new position in First Trust Nasdaq Pharmaceuticals ETF during the fourth quarter worth $230,000.

First Trust Nasdaq Pharmaceuticals ETF Company Profile

The First Trust Nasdaq Pharmaceuticals ETF (FTXH) is an exchange-traded fund that is based on the Nasdaq US Smart Pharmaceuticals index. The fund tracks the 30 most liquid US pharmaceutical companies, weighted according to factors related to value, volatility, and growth. FTXH was launched on Sep 20, 2016 and is managed by First Trust.